Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Assets Average: 2020-2024

Historic Assets Average for Eton Pharmaceuticals (ETON) over the last 5 years, with Dec 2024 value amounting to $53.9 million.

  • Eton Pharmaceuticals' Assets Average rose 204.72% to $103.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.1 million, marking a year-over-year increase of 204.72%. This contributed to the annual value of $53.9 million for FY2024, which is 90.00% up from last year.
  • As of FY2024, Eton Pharmaceuticals' Assets Average stood at $53.9 million, which was up 90.00% from $28.4 million recorded in FY2023.
  • Eton Pharmaceuticals' 5-year Assets Average high stood at $53.9 million for FY2024, and its period low was $21.7 million during FY2020.
  • Its 3-year average for Assets Average is $36.2 million, with a median of $28.4 million in 2023.
  • In the last 5 years, Eton Pharmaceuticals' Assets Average decreased by 2.40% in 2022 and then spiked by 90.00% in 2024.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Assets Average stood at $21.7 million in 2020, then grew by 23.95% to $26.9 million in 2021, then fell by 2.40% to $26.2 million in 2022, then grew by 8.14% to $28.4 million in 2023, then spiked by 90.00% to $53.9 million in 2024.